Assoc. Prof. Dr. Ashwin Jagannath Mali | Biomaterials | Biomaterials Excellence
Poona College of Pharmacy Pune | India
Assoc. Prof. Dr. Ashwin Jagannath Mali is an accomplished pharmaceutical scientist and academic leader currently serving as the Head of the Department of Industrial Pharmacy at Bharati Vidyapeeth (Deemed to be) University, Poona College of Pharmacy, Pune, India. With over 18 years of academic and research experience, he has made significant contributions to the fields of pharmaceutics, particle engineering, and drug delivery systems. Dr. Mali’s research primarily focuses on the design and development of innovative dosage forms, including dry powder inhalers, micellar systems, and nanocarriers for enhanced therapeutic efficacy. He has authored 21 scientific publications, received 180 citations from 151 documents, and holds an h-index of 8, reflecting his growing influence in the pharmaceutical sciences community. His contributions extend beyond publications to include patents, book chapters, and numerous presentations at international and national conferences. He has successfully led and collaborated on multiple funded research and industrial consultancy projects, fostering translational outcomes between academia and pharmaceutical industries. Under his mentorship, several postgraduate and doctoral students have undertaken impactful research contributing to advancements in drug formulation and delivery. Known for his commitment to academic excellence and innovation, Dr. Mali actively promotes research-based learning and industry collaboration. His efforts in bridging the gap between fundamental pharmaceutical research and applied industrial practices have positioned him as a thought leader in his domain. A dedicated educator and innovator, Assoc. Prof. Dr. Ashwin Jagannath Mali continues to drive progress in pharmaceutical technology, ensuring that his research translates into real-world health benefits, thereby strengthening his reputation as one of the leading contributors to modern drug delivery science in India and beyond.
Profiles: Scopus | Orcid | Google Scholar
Featured Publications
Kumbhar, S., Bobade, C., Velapure, P., Pawade, D., Bothiraja, C., Shinde, V., & Mali, A. (2025). Exploring the albumin nanoparticles as the next-generation advanced multifunctional biomaterials for inhalation lung therapy: Facts, prospects, and challenges. Biomedical Materials & Devices.
Panda, B. K., Bothiraja, C., Ghodke, S., Mali, A., & Kamble, R. (2024). Investigation of magnesium aluminometasilicate (Neusilin US2) based surface solid dispersion of sorafenib tosylate using QbD approach: In vitro and in vivo pharmacokinetic study. ADMET and DMPK, 12(3), 2338.
Kamble, R. N., Kausar, E., Kawadiwale, M. S., & Mali, A. J. (2023). Development and characterization of linezolid-loaded biocompatible solid lipid-based nanocarrier for enhanced lung deposition and anti-tubercular activity: Next-generation tailor-made carrier for dry powder inhaler. Current Indian Science, 3(8), 103042.
Bothiraja, C., Kashid, S., Pawar, A., & Mali, A. (2022). Investigation of dimyristoyl phosphatidyl glycerol and cholesterol-based nanocochleates as a potential oral delivery carrier for methotrexate. Journal of Liposome Research, 32(5), 402–412.
Mali, A. J., Joshi, P. A., Bothiraja, C., & Pawar, A. P. (2021). Fabrication and application of dimyristoyl phosphatidylcholine biomaterial-based nanocochleates dry powder inhaler for controlled release resveratrol delivery. Future Journal of Pharmaceutical Sciences, 7, 189.
Patel, K., Bothiraja, C., Mali, A., & Kamble, R. (2021). Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small cell lung cancer. Particulate Science and Technology, 39(8), 1016–1026.